P
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- 45.3 KBSomaxon Pharmaceuticals, Inc.Oct 4, 7:56 PM ET·0001209191-11-050483
- 8-K586.0 KBSomaxon Pharmaceuticals, Inc.Jun 13, 4:31 PM ET·0000950123-11-058670
- 45.4 KBSomaxon Pharmaceuticals, Inc.Oct 2, 7:23 PM ET·0001209191-09-047090
- SC 13D/A540.2 KBSomaxon Pharmaceuticals, Inc.May 19, 5:24 PM ET·0001132413-08-000078
- SC 13G/A36.1 KBSomaxon Pharmaceuticals, Inc.Jun 11, 1:35 PM ET·0001318148-07-000909
- 46.0 KBSomaxon Pharmaceuticals, Inc.May 10, 1:53 PM ET·0001209191-07-029284
- 413.6 KBSomaxon Pharmaceuticals, Inc.May 10, 1:53 PM ET·0001209191-07-029283
- 417.8 KBSomaxon Pharmaceuticals, Inc.May 10, 1:52 PM ET·0001209191-07-029282
- 10-Q446.8 KBSomaxon Pharmaceuticals, Inc.May 10, 8:30 AM ET·0000950134-07-011017
- 45.3 KBSomaxon Pharmaceuticals, Inc.May 9, 6:01 PM ET·0001209191-07-029116
Insiders
10- Cohen Kenneth MDirector, President and CEO
- Dorsey BrianVP Product Development
- Dube SusanSenior VP, Corp and Bus Dev
- EVNIN LUKE10% Owner
- GADICKE ANSBERT10% Owner
- GALAKATOS NICHOLAS10% Owner
- GLENN SCOTT LDirector
- HALE DAVID FDirector, Executive Chairman
- HENNER DENNIS10% Owner
- Jochelson PhilipSenior VP and Chief Medical
Tickers
No tickers on record
Addresses
business
440 STEVENS AVENUE, SUITE 200
SOLANA BEACH, CA, 92075
mailing
440 STEVENS AVENUE, SUITE 200
SOLANA BEACH, CA, 92075
Former Names
- Somaxon Pharmaceuticals, Inc.2013-02-14